Kathy D. Miller, MD
Ballvé Lantero Professor of Oncology
Professor of Medicine
Program Leader - Breast
Assistant Division Director - Research
- Address
-
Walther Hall
980 W. Walnut Street
RT 473
Indianapolis, Indian 46202 - PubMed:
Bio
Dr. Kathy Miller is a professor of oncology and medicine for IU School of Medicine Department of Medicine Hematology/Oncology Division.
| Year | Degree | Institution |
|---|---|---|
| 1997 | Fellowship | Indiana University School of Medicine, Indianapolis, IN |
| 1994 | Residency | Johns Hopkins School of Medicine, Baltimore, MD |
| 1991 | MD | Johns Hopkins University |
| 1986 | BS | University of Miami |
Breast Cancer
Association Between Surgery Preference and Receipt in Ductal Carcinoma In Situ After Breast Magnetic Resonance Imaging: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112).
Fazeli S; Snyder BS; Gareen IF; Lehman CD; Khan SA; Romanoff J; Gatsonis CA; Corsetti RL; Rahbar H; Spell DW; Blankstein KB; Han LK; Sabol JL; Bumberry JR; Miller KD; Sparano JA; Comstock CE; Wagner LI; Carlos RC; JAMA network open 2022 May 2
Fazeli S; Snyder BS; Gareen IF; Lehman CD; Khan SA; Romanoff J; Gatsonis CA; Corsetti RL; Rahbar H; Spell DW; Blankstein KB; Han LK; Sabol JL; Bumberry JR; Miller KD; Sparano JA; Comstock CE; Wagner LI; Carlos RC; JAMA network open 2022 May 2
Impact of African ancestry on the relationship between body mass index and survival in an early-stage breast cancer trial (ECOG-ACRIN E5103).
Ballinger TJ; Jiang G; Shen F; Miller KD; Sledge GW Jr; Schneider BP; Cancer 2022 Mar 14
Ballinger TJ; Jiang G; Shen F; Miller KD; Sledge GW Jr; Schneider BP; Cancer 2022 Mar 14
Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03).
Mayer EL; Fesl C; Hlauschek D; Garcia-Estevez L; Burstein HJ; Zdenkowski N; Wette V; Miller KD; Balic M; Mayer IA; Cameron D; Winer EP; Ponce Lorenzo JJ; Lake D; Pristauz-Telsnigg G; Haddad TC; Shepherd L; Iwata H; Goetz M; Cardoso F; Traina TA; Sabanathan D; Breitenstein U; Ackerl K; Metzger Filho O; Zehetner K; Solomon K; El-Abed S; Theall KP; Lu DR; Dueck A; Gnant M; DeMichele A; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 Jan 7
Mayer EL; Fesl C; Hlauschek D; Garcia-Estevez L; Burstein HJ; Zdenkowski N; Wette V; Miller KD; Balic M; Mayer IA; Cameron D; Winer EP; Ponce Lorenzo JJ; Lake D; Pristauz-Telsnigg G; Haddad TC; Shepherd L; Iwata H; Goetz M; Cardoso F; Traina TA; Sabanathan D; Breitenstein U; Ackerl K; Metzger Filho O; Zehetner K; Solomon K; El-Abed S; Theall KP; Lu DR; Dueck A; Gnant M; DeMichele A; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 Jan 7
Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer.
Sparano JA; O'Neill A; Graham N; Northfelt DW; Dang CT; Wolff AC; Sledge GW; Miller KD; NPJ breast cancer 2022 Feb 8
Sparano JA; O'Neill A; Graham N; Northfelt DW; Dang CT; Wolff AC; Sledge GW; Miller KD; NPJ breast cancer 2022 Feb 8
Quality of Life Following Receipt of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer.
Rosenberg SM; O'Neill A; Sepucha K; Miller KD; Dang CT; Northfelt DW; Sledge GW; Schneider BP; Partridge AH; JAMA network open 2022 Feb 1
Rosenberg SM; O'Neill A; Sepucha K; Miller KD; Dang CT; Northfelt DW; Sledge GW; Schneider BP; Partridge AH; JAMA network open 2022 Feb 1
Back to the Beginning: The Role of Ovarian Suppression in Management of Hormone Sensitive Breast Cancer in Premenopausal Women.
Connolly RM; Miller KD; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 Dec 15
Connolly RM; Miller KD; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 Dec 15
Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer.
Radovich M; Solzak JP; Wang CJ; Hancock BA; Badve S; Althouse SK; Bray SM; Storniolo AMV; Ballinger TJ; Schneider BP; Miller KD; Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Aug 2
Radovich M; Solzak JP; Wang CJ; Hancock BA; Badve S; Althouse SK; Bray SM; Storniolo AMV; Ballinger TJ; Schneider BP; Miller KD; Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Aug 2
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609).
Adams S; Othus M; Patel SP; Miller KD; Chugh R; Schuetze SM; Chamberlin MD; Haley BJ; Storniolo AMV; Reddy MP; Anderson SA; Zimmerman CT; O'Dea AP; Mirshahidi HR; Ahnert JR; Brescia FJ; Hahn O; Raymond JM; Biggs DD; Connolly RM; Sharon E; Korde LA; Gray RJ; Mayerson E; Plets M; Blanke CD; Chae YK; Kurzrock R; Clinical cancer research : an official journal of the American Association for Cancer Research 2021 Oct 29
Adams S; Othus M; Patel SP; Miller KD; Chugh R; Schuetze SM; Chamberlin MD; Haley BJ; Storniolo AMV; Reddy MP; Anderson SA; Zimmerman CT; O'Dea AP; Mirshahidi HR; Ahnert JR; Brescia FJ; Hahn O; Raymond JM; Biggs DD; Connolly RM; Sharon E; Korde LA; Gray RJ; Mayerson E; Plets M; Blanke CD; Chae YK; Kurzrock R; Clinical cancer research : an official journal of the American Association for Cancer Research 2021 Oct 29
Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2-negative breast cancer: A trajectory analysis of adverse events.
Ip EH; Saldana S; Miller KD; Carlos RC; Gareen IF; Sparano JA; Graham N; Zhao F; Lee JW; O'Connell NS; Cella D; Peipert JD; Gray RJ; Wagner LI; Cancer 2021 Nov 2
Ip EH; Saldana S; Miller KD; Carlos RC; Gareen IF; Sparano JA; Graham N; Zhao F; Lee JW; O'Connell NS; Cella D; Peipert JD; Gray RJ; Wagner LI; Cancer 2021 Nov 2
Patient-Reported Testing Burden of Breast Magnetic Resonance Imaging Among Women With Ductal Carcinoma In Situ: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112).
Fazeli S; Snyder BS; Gareen IF; Lehman CD; Khan SA; Romanoff J; Gatsonis CA; Miller KD; Sparano JA; Comstock CE; Wagner LI; Carlos RC; JAMA network open 2021 Nov 1
Fazeli S; Snyder BS; Gareen IF; Lehman CD; Khan SA; Romanoff J; Gatsonis CA; Miller KD; Sparano JA; Comstock CE; Wagner LI; Carlos RC; JAMA network open 2021 Nov 1
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03).
Gnant M; Dueck AC; Frantal S; Martin M; Burstein HJ; Greil R; Fox P; Wolff AC; Chan A; Winer EP; Pfeiler G; Miller KD; Colleoni M; Suga JM; Rubovsky G; Bliss JM; Mayer IA; Singer CF; Nowecki Z; Hahn O; Thomson J; Wolmark N; Amillano K; Rugo HS; Steger GG; Hernando Fernández de Aránguiz B; Haddad TC; Perelló A; Bellet M; Fohler H; Metzger Filho O; Jallitsch-Halper A; Solomon K; Schurmans C; Theall KP; Lu DR; Tenner K; Fesl C; DeMichele A; Mayer EL; PALLAS groups and investigators; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 Dec 7
Gnant M; Dueck AC; Frantal S; Martin M; Burstein HJ; Greil R; Fox P; Wolff AC; Chan A; Winer EP; Pfeiler G; Miller KD; Colleoni M; Suga JM; Rubovsky G; Bliss JM; Mayer IA; Singer CF; Nowecki Z; Hahn O; Thomson J; Wolmark N; Amillano K; Rugo HS; Steger GG; Hernando Fernández de Aránguiz B; Haddad TC; Perelló A; Bellet M; Fohler H; Metzger Filho O; Jallitsch-Halper A; Solomon K; Schurmans C; Theall KP; Lu DR; Tenner K; Fesl C; DeMichele A; Mayer EL; PALLAS groups and investigators; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 Dec 7
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer.
Schneider BP; Jiang G; Ballinger TJ; Shen F; Chitambar C; Nanda R; Falkson C; Lynce FC; Gallagher C; Isaacs C; Blaya M; Paplomata E; Walling R; Daily K; Mahtani R; Thompson MA; Graham R; Cooper ME; Pavlick DC; Albacker LA; Gregg J; Solzak JP; Chen YH; Bales CL; Cantor E; Hancock BA; Kassem N; Helft P; O'Neil B; Storniolo AMV; Badve S; Miller KD; Radovich M; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 Dec 15
Schneider BP; Jiang G; Ballinger TJ; Shen F; Chitambar C; Nanda R; Falkson C; Lynce FC; Gallagher C; Isaacs C; Blaya M; Paplomata E; Walling R; Daily K; Mahtani R; Thompson MA; Graham R; Cooper ME; Pavlick DC; Albacker LA; Gregg J; Solzak JP; Chen YH; Bales CL; Cantor E; Hancock BA; Kassem N; Helft P; O'Neil B; Storniolo AMV; Badve S; Miller KD; Radovich M; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 Dec 15
A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma.
Mayer EL; DeMichele A; Rugo HS; Miller K; Waks AG; Come SE; Mulvey T; Jeselsohn R; Overmoyer B; Guo H; Barry WT; Huang Bartlett C; Koehler M; Winer EP; Burstein HJ; Annals of oncology : official journal of the European Society for Medical Oncology 2019 Sep 1
Mayer EL; DeMichele A; Rugo HS; Miller K; Waks AG; Come SE; Mulvey T; Jeselsohn R; Overmoyer B; Guo H; Barry WT; Huang Bartlett C; Koehler M; Winer EP; Burstein HJ; Annals of oncology : official journal of the European Society for Medical Oncology 2019 Sep 1
Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off.
Upshaw JN; Ruthazer R; Miller KD; Parsons SK; Erban JK; O'Neill AM; Demissei B; Sledge G; Wagner L; Ky B; Kent DM; Clinical breast cancer 2019 May 2
Upshaw JN; Ruthazer R; Miller KD; Parsons SK; Erban JK; O'Neill AM; Demissei B; Sledge G; Wagner L; Ky B; Kent DM; Clinical breast cancer 2019 May 2
Poly-ADP-Ribosylation of Estrogen Receptor-Alpha by PARP1 Mediates Antiestrogen Resistance in Human Breast Cancer Cells.
Pulliam N; Tang J; Wang W; Fang F; Sood R; O'Hagan HM; Miller KD; Clarke R; Nephew KP; Cancers 2019 Jan 4
Pulliam N; Tang J; Wang W; Fang F; Sood R; O'Hagan HM; Miller KD; Clarke R; Nephew KP; Cancers 2019 Jan 4
Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ Treatment.
Lehman CD; Gatsonis C; Romanoff J; Khan SA; Carlos R; Solin LJ; Badve S; McCaskill-Stevens W; Corsetti RL; Rahbar H; Spell DW; Blankstein KB; Han LK; Sabol JL; Bumberry JR; Gareen I; Snyder BS; Wagner LI; Miller KD; Sparano JA; Comstock C; 2019 Jan 17
Lehman CD; Gatsonis C; Romanoff J; Khan SA; Carlos R; Solin LJ; Badve S; McCaskill-Stevens W; Corsetti RL; Rahbar H; Spell DW; Blankstein KB; Han LK; Sabol JL; Bumberry JR; Gareen I; Snyder BS; Wagner LI; Miller KD; Sparano JA; Comstock C; 2019 Jan 17
Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers.
Hancock BA; Chen YH; Solzak JP; Ahmad MN; Wedge DC; Brinza D; Scafe C; Veitch J; Gottimukkala R; Short W; Atale RV; Ivan M; Badve SS; Schneider BP; Lu X; Miller KD; Radovich M; Breast cancer research : BCR 2019 Aug 5
Hancock BA; Chen YH; Solzak JP; Ahmad MN; Wedge DC; Brinza D; Scafe C; Veitch J; Gottimukkala R; Short W; Atale RV; Ivan M; Badve SS; Schneider BP; Lu X; Miller KD; Radovich M; Breast cancer research : BCR 2019 Aug 5
Dual TGFß/BMP Pathway Inhibition Enables Expansion and Characterization of Multiple Epithelial Cell Types of the Normal and Cancerous Breast.
Prasad M; Kumar B; Bhat-Nakshatri P; Anjanappa M; Sandusky G; Miller KD; Storniolo AM; Nakshatri H; Molecular cancer research : MCR 2019 Apr 16
Prasad M; Kumar B; Bhat-Nakshatri P; Anjanappa M; Sandusky G; Miller KD; Storniolo AM; Nakshatri H; Molecular cancer research : MCR 2019 Apr 16
Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study.
Munster P; Krop IE; LoRusso P; Ma C; Siegel BA; Shields AF; Molnár I; Wickham TJ; Reynolds J; Campbell K; Hendriks BS; Adiwijaya BS; Geretti E; Moyo V; Miller KD; 2018 Oct 26
Munster P; Krop IE; LoRusso P; Ma C; Siegel BA; Shields AF; Molnár I; Wickham TJ; Reynolds J; Campbell K; Hendriks BS; Adiwijaya BS; Geretti E; Moyo V; Miller KD; 2018 Oct 26
Metastatic breast cancer patients' expectations and priorities for symptom improvement.
Tometich DB; Mosher CE; Hirsh AT; Rand KL; Johns SA; Matthias MS; Outcalt SD; Schneider BP; Mina L; Storniolo AMV; Newton EV; Miller KD; Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2018 May 7
Tometich DB; Mosher CE; Hirsh AT; Rand KL; Johns SA; Matthias MS; Outcalt SD; Schneider BP; Mina L; Storniolo AMV; Newton EV; Miller KD; Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2018 May 7
Using a Neoadjuvant Approach for Evaluating Novel Therapies for Patients With Breast Cancer.
Denduluri N; Miller K; O'Regan RM; 2018 May 23
Denduluri N; Miller K; O'Regan RM; 2018 May 23
Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103).
Miller KD; O'Neill A; Gradishar W; Hobday TJ; Goldstein LJ; Mayer IA; Bloom S; Brufsky AM; Tevaarwerk AJ; Sparano JA; Le-Lindqwister NA; Hendricks CB; Northfelt DW; Dang CT; Sledge GW Jr; 2018 Jul 24
Miller KD; O'Neill A; Gradishar W; Hobday TJ; Goldstein LJ; Mayer IA; Bloom S; Brufsky AM; Tevaarwerk AJ; Sparano JA; Le-Lindqwister NA; Hendricks CB; Northfelt DW; Dang CT; Sledge GW Jr; 2018 Jul 24
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.
Traina TA; Miller K; Yardley DA; Eakle J; Schwartzberg LS; O'Shaughnessy J; Gradishar W; Schmid P; Winer E; Kelly C; Nanda R; Gucalp A; Awada A; Garcia-Estevez L; Trudeau ME; Steinberg J; Uppal H; Tudor IC; Peterson A; Cortes J; 2018 Jan 26
Traina TA; Miller K; Yardley DA; Eakle J; Schwartzberg LS; O'Shaughnessy J; Gradishar W; Schmid P; Winer E; Kelly C; Nanda R; Gucalp A; Awada A; Garcia-Estevez L; Trudeau ME; Steinberg J; Uppal H; Tudor IC; Peterson A; Cortes J; 2018 Jan 26
Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial.
Mosher CE; Secinti E; Li R; Hirsh AT; Bricker J; Miller KD; Schneider B; Storniolo AM; Mina L; Newton EV; Champion VL; Johns SA; Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2018 Jan 12
Mosher CE; Secinti E; Li R; Hirsh AT; Bricker J; Miller KD; Schneider B; Storniolo AM; Mina L; Newton EV; Champion VL; Johns SA; Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2018 Jan 12
E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer.
Yeruva SLH; Zhao F; Miller KD; Tevaarwerk AJ; Wagner LI; Gray RJ; Sparano JA; Connolly RM; 2018 Jan 11
Yeruva SLH; Zhao F; Miller KD; Tevaarwerk AJ; Wagner LI; Gray RJ; Sparano JA; Connolly RM; 2018 Jan 11
Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Sparano J; O'Neill A; Alpaugh K; Wolff AC; Northfelt DW; Dang CT; Sledge GW; Miller KD; 2018 Dec 1
Sparano J; O'Neill A; Alpaugh K; Wolff AC; Northfelt DW; Dang CT; Sledge GW; Miller KD; 2018 Dec 1
The implications of insurance status on presentation, surgical management, and mortality among nonmetastatic breast cancer patients in Indiana.
Obeng-Gyasi S; Timsina L; Miller KD; Ludwig KK; Fisher CS; Haggstrom DA; 2018 Aug 28
Obeng-Gyasi S; Timsina L; Miller KD; Ludwig KK; Fisher CS; Haggstrom DA; 2018 Aug 28
Impact of primary breast cancer therapy on energetic capacity and body composition.
Ballinger TJ; Reddy A; Althouse SK; Nelson EM; Miller KD; Sledge JS; Breast cancer research and treatment 2018 Aug 22
Ballinger TJ; Reddy A; Althouse SK; Nelson EM; Miller KD; Sledge JS; Breast cancer research and treatment 2018 Aug 22
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer.
Diamond JR; Eckhardt SG; Pitts TM; van Bokhoven A; Aisner D; Gustafson DL; Capasso A; Sams S; Kabos P; Zolman K; Colvin T; Elias AD; Storniolo AM; Schneider BP; Gao D; Tentler JJ; Borges VF; Miller KD; 2018 Aug 2
Diamond JR; Eckhardt SG; Pitts TM; van Bokhoven A; Aisner D; Gustafson DL; Capasso A; Sams S; Kabos P; Zolman K; Colvin T; Elias AD; Storniolo AM; Schneider BP; Gao D; Tentler JJ; Borges VF; Miller KD; 2018 Aug 2
An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations.
Pulliam N; Fang F; Ozes AR; Tang J; Adewuyi A; Keer H; Lyons J; Baylin SB; Matei D; Nakshatri H; Rassool FV; Miller KD; Nephew KP; 2018 Apr 3
Pulliam N; Fang F; Ozes AR; Tang J; Adewuyi A; Keer H; Lyons J; Baylin SB; Matei D; Nakshatri H; Rassool FV; Miller KD; Nephew KP; 2018 Apr 3
Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102.
Kornblum N; Zhao F; Manola J; Klein P; Ramaswamy B; Brufsky A; Stella PJ; Burnette B; Telli M; Makower DF; Cheema P; Truica CI; Wolff AC; Soori GS; Haley B; Wassenaar TR; Goldstein LJ; Miller KD; Sparano JA; 2018 Apr 17
Kornblum N; Zhao F; Manola J; Klein P; Ramaswamy B; Brufsky A; Stella PJ; Burnette B; Telli M; Makower DF; Cheema P; Truica CI; Wolff AC; Soori GS; Haley B; Wassenaar TR; Goldstein LJ; Miller KD; Sparano JA; 2018 Apr 17
A system for detecting high impact-low frequency mutations in primary tumors and metastases.
Anjanappa M; Hao Y; Simpson ER; Bhat-Nakshatri P; Nelson JB; Tersey SA; Mirmira RG; Cohen-Gadol AA; Saadatzadeh MR; Li L; Fang F; Nephew KP; Miller KD; Liu Y; Nakshatri H; Oncogene 2017 Sep 11
Anjanappa M; Hao Y; Simpson ER; Bhat-Nakshatri P; Nelson JB; Tersey SA; Mirmira RG; Cohen-Gadol AA; Saadatzadeh MR; Li L; Fang F; Nephew KP; Miller KD; Liu Y; Nakshatri H; Oncogene 2017 Sep 11
Survival benefit needed to undergo chemotherapy: Patient and physician preferences.
Vaz-Luis I; O'Neill A; Sepucha K; Miller KD; Baker E; Dang CT; Northfelt DW; Winer EP; Sledge GW; Schneider B; Partridge AH; Cancer 2017 Mar 21
Vaz-Luis I; O'Neill A; Sepucha K; Miller KD; Baker E; Dang CT; Northfelt DW; Winer EP; Sledge GW; Schneider B; Partridge AH; Cancer 2017 Mar 21
<sup>64</sup>Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer.
Lee H; Shields AF; Siegel BA; Miller KD; Krop I; Ma CX; LoRusso PM; Munster PN; Campbell K; Gaddy DF; Leonard SC; Geretti E; Blocker SJ; Kirpotin DB; Moyo V; Wickham TJ; Hendriks BS; Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Mar 15
Lee H; Shields AF; Siegel BA; Miller KD; Krop I; Ma CX; LoRusso PM; Munster PN; Campbell K; Gaddy DF; Leonard SC; Geretti E; Blocker SJ; Kirpotin DB; Moyo V; Wickham TJ; Hendriks BS; Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Mar 15
Questioning Our APHINITY for More.
Miller KD; The New England journal of medicine 2017 Jun 5
Miller KD; The New England journal of medicine 2017 Jun 5
Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy?
Partridge AH; Sepucha K; O'Neill A; Miller KD; Baker E; Dang CT; Northfelt DW; Sledge GW; Schneider BP; Breast cancer research and treatment 2017 Jun 23
Partridge AH; Sepucha K; O'Neill A; Miller KD; Baker E; Dang CT; Northfelt DW; Sledge GW; Schneider BP; Breast cancer research and treatment 2017 Jun 23
Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy.
Chen YH; Hancock BA; Solzak JP; Brinza D; Scafe C; Miller KD; Radovich M; NPJ breast cancer 2017 Jul 3
Chen YH; Hancock BA; Solzak JP; Brinza D; Scafe C; Miller KD; Radovich M; NPJ breast cancer 2017 Jul 3
Impact of Genetic Ancestry on Outcomes in ECOG-ACRIN-E5103.
Schneider BP; Shen F; Jiang G; O'Neill A; Radovich M; Li L; Gardner L; Lai D; Foroud T; Sparano JA; Sledge GW Jr; Miller KD; 2017 Aug 21
Schneider BP; Shen F; Jiang G; O'Neill A; Radovich M; Li L; Gardner L; Lai D; Foroud T; Sparano JA; Sledge GW Jr; Miller KD; 2017 Aug 21
Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African-Americans.
Schneider BP; Lai D; Shen F; Jiang G; Radovich M; Li L; Gardner L; Miller KD; O'Neill A; Sparano JA; Xue G; Foroud T; Sledge GW Jr; Oncotarget 2016 Oct 9
Schneider BP; Lai D; Shen F; Jiang G; Radovich M; Li L; Gardner L; Miller KD; O'Neill A; Sparano JA; Xue G; Foroud T; Sledge GW Jr; Oncotarget 2016 Oct 9
Randomized controlled pilot trial of mindfulness-based stress reduction compared to psychoeducational support for persistently fatigued breast and colorectal cancer survivors.
Johns SA; Brown LF; Beck-Coon K; Talib TL; Monahan PO; Giesler RB; Tong Y; Wilhelm L; Carpenter JS; Von Ah D; Wagner CD; de Groot M; Schmidt K; Monceski D; Danh M; Alyea JM; Miller KD; Kroenke K; Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2016 May 17
Johns SA; Brown LF; Beck-Coon K; Talib TL; Monahan PO; Giesler RB; Tong Y; Wilhelm L; Carpenter JS; Von Ah D; Wagner CD; de Groot M; Schmidt K; Monceski D; Danh M; Alyea JM; Miller KD; Kroenke K; Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2016 May 17
Role of RPL39 in Metaplastic Breast Cancer.
Dave B; Gonzalez DD; Liu ZB; Li X; Wong H; Granados S; Ezzedine NE; Sieglaff DH; Ensor JE; Miller KD; Radovich M; KarinaEtrovic A; Gross SS; Elemento O; Mills GB; Gilcrease MZ; Chang JC; Journal of the National Cancer Institute 2016 Dec 31
Dave B; Gonzalez DD; Liu ZB; Li X; Wong H; Granados S; Ezzedine NE; Sieglaff DH; Ensor JE; Miller KD; Radovich M; KarinaEtrovic A; Gross SS; Elemento O; Mills GB; Gilcrease MZ; Chang JC; Journal of the National Cancer Institute 2016 Dec 31
Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure.
Schneider BP; Shen F; Gardner L; Radovich M; Li L; Miller KD; Jiang G; Lai D; O'Neill A; Sparano JA; Davidson NE; Cameron D; Gradus-Pizlo I; Mastouri RA; Suter TM; Foroud T; Sledge GW Jr; Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Dec 19
Schneider BP; Shen F; Gardner L; Radovich M; Li L; Miller KD; Jiang G; Lai D; O'Neill A; Sparano JA; Davidson NE; Cameron D; Gradus-Pizlo I; Mastouri RA; Suter TM; Foroud T; Sledge GW Jr; Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Dec 19
Are There Differences in Treatment and Survival Between Poor, Older Black and White Women with Breast Cancer?
Aggarwal H; Callahan CM; Miller KD; Tu W; Loehrer PJ Sr; Journal of the American Geriatrics Society 2015 Oct 12
Aggarwal H; Callahan CM; Miller KD; Tu W; Loehrer PJ Sr; Journal of the American Geriatrics Society 2015 Oct 12
Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199.
Schneider BP; Li L; Radovich M; Shen F; Miller KD; Flockhart DA; Jiang G; Vance G; Gardner L; Vatta M; Bai S; Lai D; Koller D; Zhao F; O'Neill A; Smith ML; Railey E; White C; Partridge A; Sparano J; Davidson NE; Foroud T; Sledge GW Jr; Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Jul 2
Schneider BP; Li L; Radovich M; Shen F; Miller KD; Flockhart DA; Jiang G; Vance G; Gardner L; Vatta M; Bai S; Lai D; Koller D; Zhao F; O'Neill A; Smith ML; Railey E; White C; Partridge A; Sparano J; Davidson NE; Foroud T; Sledge GW Jr; Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Jul 2
TFAP2C expression in breast cancer: correlation with overall survival beyond 10 years of initial diagnosis.
Perkins SM; Bales C; Vladislav T; Althouse S; Miller KD; Sandusky G; Badve S; Nakshatri H; Breast cancer research and treatment 2015 Jul 10
Perkins SM; Bales C; Vladislav T; Althouse S; Miller KD; Sandusky G; Badve S; Nakshatri H; Breast cancer research and treatment 2015 Jul 10
What Can We Learn about Antibody-Drug Conjugates from the T-DM1 Experience?
Esteva FJ; Miller KD; Teicher BA; American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Meeting 2015
Esteva FJ; Miller KD; Teicher BA; American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Meeting 2015
A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007.
Miller KD; Althouse SK; Nabell L; Rugo H; Carey L; Kimmick G; Jones DR; Merino MJ; Steeg PS; Breast cancer research and treatment 2014 Sep 26
Miller KD; Althouse SK; Nabell L; Rugo H; Carey L; Kimmick G; Jones DR; Merino MJ; Steeg PS; Breast cancer research and treatment 2014 Sep 26
Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.
O'Shaughnessy J; Schwartzberg L; Danso MA; Miller KD; Rugo HS; Neubauer M; Robert N; Hellerstedt B; Saleh M; Richards P; Specht JM; Yardley DA; Carlson RW; Finn RS; Charpentier E; Garcia-Ribas I; Winer EP; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Oct 27
O'Shaughnessy J; Schwartzberg L; Danso MA; Miller KD; Rugo HS; Neubauer M; Robert N; Hellerstedt B; Saleh M; Richards P; Specht JM; Yardley DA; Carlson RW; Finn RS; Charpentier E; Garcia-Ribas I; Winer EP; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Oct 27
Comparison of younger and older breast cancer survivors and age-matched controls on specific and overall quality of life domains.
Champion VL; Wagner LI; Monahan PO; Daggy J; Smith L; Cohee A; Ziner KW; Haase JE; Miller KD; Pradhan K; Unverzagt FW; Cella D; Ansari B; Sledge GW Jr; Cancer 2014 May 28
Champion VL; Wagner LI; Monahan PO; Daggy J; Smith L; Cohee A; Ziner KW; Haase JE; Miller KD; Pradhan K; Unverzagt FW; Cella D; Ansari B; Sledge GW Jr; Cancer 2014 May 28
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.
Schneider BP; Li L; Shen F; Miller KD; Radovich M; O'Neill A; Gray RJ; Lane D; Flockhart DA; Jiang G; Wang Z; Lai D; Koller D; Pratt JH; Dang CT; Northfelt D; Perez EA; Shenkier T; Cobleigh M; Smith ML; Railey E; Partridge A; Gralow J; Sparano J; Davidson NE; Foroud T; Sledge GW; British journal of cancer 2014 Aug 12
Schneider BP; Li L; Shen F; Miller KD; Radovich M; O'Neill A; Gray RJ; Lane D; Flockhart DA; Jiang G; Wang Z; Lai D; Koller D; Pratt JH; Dang CT; Northfelt D; Perez EA; Shenkier T; Cobleigh M; Smith ML; Railey E; Partridge A; Gralow J; Sparano J; Davidson NE; Foroud T; Sledge GW; British journal of cancer 2014 Aug 12
Phase IIa trial of trastuzumab emtansine with pertuzumab for patients with human epidermal growth factor receptor 2-positive, locally advanced, or metastatic breast cancer.
Miller KD; Diéras V; Harbeck N; Andre F; Mahtani RL; Gianni L; Albain KS; Crivellari D; Fang L; Michelson G; de Haas SL; Burris HA; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Apr 14
Miller KD; Diéras V; Harbeck N; Andre F; Mahtani RL; Gianni L; Albain KS; Crivellari D; Fang L; Michelson G; de Haas SL; Burris HA; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Apr 14
Synthesis of (Z)-2-((1H-indazol-3-yl)methylene)-6-[¹¹C]methoxy-7-(piperazin-1-ylmethyl)benzofuran-3(2H)-one as a new potential PET probe for imaging of the enzyme PIM1.
Gao M; Wang M; Miller KD; Zheng QH; Bioorganic & medicinal chemistry letters 2013 Jun 6
Gao M; Wang M; Miller KD; Zheng QH; Bioorganic & medicinal chemistry letters 2013 Jun 6
A phase II study of combined VEGF inhibitor (bevacizumab+sorafenib) in patients with metastatic breast cancer: Hoosier Oncology Group Study BRE06-109.
Mina LA; Yu M; Johnson C; Burkhardt C; Miller KD; Zon R; Investigational new drugs 2013 Jun 28
Mina LA; Yu M; Johnson C; Burkhardt C; Miller KD; Zon R; Investigational new drugs 2013 Jun 28
Synthesis of radiolabeled protein disulfide isomerase (PDI) inhibitors as new potential PET agents for imaging of the enzyme PDI in neurological disorders and cancer.
Gao M; Yang Q; Wang M; Miller KD; Sledge GW; Zheng QH; Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2013 Jan 8
Gao M; Yang Q; Wang M; Miller KD; Sledge GW; Zheng QH; Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2013 Jan 8
Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial.
Schneider BP; Gray RJ; Radovich M; Shen F; Vance G; Li L; Jiang G; Miller KD; Gralow JR; Dickler MN; Cobleigh MA; Perez EA; Shenkier TN; Vang Nielsen K; Müller S; Thor A; Sledge GW Jr; Sparano JA; Davidson NE; Badve SS; Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Jan 22
Schneider BP; Gray RJ; Radovich M; Shen F; Vance G; Li L; Jiang G; Miller KD; Gralow JR; Dickler MN; Cobleigh MA; Perez EA; Shenkier TN; Vang Nielsen K; Müller S; Thor A; Sledge GW Jr; Sparano JA; Davidson NE; Badve SS; Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Jan 22
Health-related quality of life of african american breast cancer survivors compared with healthy African American women.
Von Ah DM; Russell KM; Carpenter J; Monahan PO; Qianqian Z; Tallman E; Ziner KW; Storniolo AM; Miller KD; Giesler RB; Haase J; Otte J; Champion VL; Cancer nursing 2012 Sep
Von Ah DM; Russell KM; Carpenter J; Monahan PO; Qianqian Z; Tallman E; Ziner KW; Storniolo AM; Miller KD; Giesler RB; Haase J; Otte J; Champion VL; Cancer nursing 2012 Sep
Pharmacogenetic biomarkers for the prediction of response to antiangiogenic treatment.
Schneider BP; Shen F; Miller KD; The Lancet. Oncology 2012 Oct
Schneider BP; Shen F; Miller KD; The Lancet. Oncology 2012 Oct
Predicting fear of breast cancer recurrence and self-efficacy in survivors by age at diagnosis.
Ziner KW; Sledge GW; Bell CJ; Johns S; Miller KD; Champion VL; Oncology nursing forum 2012 May 1
Ziner KW; Sledge GW; Bell CJ; Johns S; Miller KD; Champion VL; Oncology nursing forum 2012 May 1
A brief intervention to minimize psychosexual morbidity in dyads coping with breast cancer.
Decker CL; Pais S; Miller KD; Goulet R; Fifea BL; Oncology nursing forum 2012 Mar
Decker CL; Pais S; Miller KD; Goulet R; Fifea BL; Oncology nursing forum 2012 Mar
[11C]GSK2126458 and [18F]GSK2126458, the first radiosynthesis of new potential PET agents for imaging of PI3K and mTOR in cancers.
Wang M; Gao M; Miller KD; Sledge GW; Zheng QH; Bioorganic & medicinal chemistry letters 2012 Jan 10
Wang M; Gao M; Miller KD; Sledge GW; Zheng QH; Bioorganic & medicinal chemistry letters 2012 Jan 10
Synthesis of 2,6-difluoro-N-(3-[11C]methoxy-1H-pyrazolo[3,4-b]pyridine-5-yl)-3-(propylsulfonamidio)benzamide as a new potential PET agent for imaging of B-Raf(V600E) in cancers.
Wang M; Gao M; Miller KD; Zheng QH; Bioorganic & medicinal chemistry letters 2012 Dec 20
Wang M; Gao M; Miller KD; Zheng QH; Bioorganic & medicinal chemistry letters 2012 Dec 20
Cognitive appraisals, coping and depressive symptoms in breast cancer patients.
Bigatti SM; Steiner JL; Miller KD; Stress and health : journal of the International Society for the Investigation of Stress 2012 Aug 10
Bigatti SM; Steiner JL; Miller KD; Stress and health : journal of the International Society for the Investigation of Stress 2012 Aug 10
Simple synthesis of carbon-11-labeled chromen-4-one derivatives as new potential PET agents for imaging of DNA-dependent protein kinase (DNA-PK) in cancer.
Gao M; Wang M; Miller KD; Zheng QH; Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2012 Apr 27
Gao M; Wang M; Miller KD; Zheng QH; Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2012 Apr 27
Synthesis of 2-[11C]methoxy-3,17ß-O,O-bis(sulfamoyl)estradiol as a new potential PET agent for imaging of steroid sulfatase (STS) in cancers.
Wang M; Xu L; Gao M; Miller KD; Sledge GW; Zheng QH; Steroids 2012 Apr 19
Wang M; Xu L; Gao M; Miller KD; Sledge GW; Zheng QH; Steroids 2012 Apr 19
Synthesis and preliminary in vitro biological evaluation of new carbon-11-labeled celecoxib derivatives as candidate PET tracers for imaging of COX-2 expression in cancer.
Gao M; Wang M; Miller KD; Zheng QH; European journal of medicinal chemistry 2011 May 20
Gao M; Wang M; Miller KD; Zheng QH; European journal of medicinal chemistry 2011 May 20
Synthesis of [¹¹C]PBR06 and [¹8F]PBR06 as agents for positron emission tomographic (PET) imaging of the translocator protein (TSPO).
Wang M; Gao M; Miller KD; Zheng QH; Steroids 2011 Jul 3
Wang M; Gao M; Miller KD; Zheng QH; Steroids 2011 Jul 3
[11C]enzastaurin, the first design and radiosynthesis of a new potential PET agent for imaging of protein kinase C.
Wang M; Xu L; Gao M; Miller KD; Sledge GW; Zheng QH; Bioorganic & medicinal chemistry letters 2011 Jan 31
Wang M; Xu L; Gao M; Miller KD; Sledge GW; Zheng QH; Bioorganic & medicinal chemistry letters 2011 Jan 31
A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group.
Miller KD; O'Neill A; Perez EA; Seidman AD; Sledge GW; Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011 Aug 4
Miller KD; O'Neill A; Perez EA; Seidman AD; Sledge GW; Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011 Aug 4
Facile radiosynthesis of new carbon-11-labeled propanamide derivatives as selective androgen receptor modulator (SARM) radioligands for prostate cancer imaging.
Gao M; Wang M; Miller KD; Zheng QH; Steroids 2011 Aug 17
Gao M; Wang M; Miller KD; Zheng QH; Steroids 2011 Aug 17
Radiosynthesis of [11C]Vandetanib and [11C]chloro-Vandetanib as new potential PET agents for imaging of VEGFR in cancer.
Gao M; Lola CM; Wang M; Miller KD; Sledge GW; Zheng QH; Bioorganic & medicinal chemistry letters 2011 Apr 20
Gao M; Lola CM; Wang M; Miller KD; Sledge GW; Zheng QH; Bioorganic & medicinal chemistry letters 2011 Apr 20
The first design and synthesis of [11C]MKC-1 ([11C]Ro 31-7453), a new potential PET cancer imaging agent.
Wang M; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH; Nuclear medicine and biology 2010 Oct
Wang M; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH; Nuclear medicine and biology 2010 Oct
The first synthesis of [(11)C]SB-216763, a new potential PET agent for imaging of glycogen synthase kinase-3 (GSK-3).
Wang M; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH; Bioorganic & medicinal chemistry letters 2010 Nov 11
Wang M; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH; Bioorganic & medicinal chemistry letters 2010 Nov 11
Facile synthesis of carbon-11-labeled cholesterol-based cationic lipids as new potential PET probes for imaging of gene delivery in cancer.
Gao M; Wang M; Miller KD; Sledge GW; Hutchins GD; Zheng QH; Steroids 2010 May 6
Gao M; Wang M; Miller KD; Sledge GW; Hutchins GD; Zheng QH; Steroids 2010 May 6
Synthesis of carbon-11-labeled tricyclic necroptosis inhibitors as new potential PET agents for imaging of tumor necrosis factor alpha (TNF-alpha).
Gao M; Lola CM; Wang M; Miller KD; Sledge GW; Hutchins GD; Zheng QH; Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2010 May 5
Gao M; Lola CM; Wang M; Miller KD; Sledge GW; Hutchins GD; Zheng QH; Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2010 May 5
Depression in husbands of breast cancer patients: relationships to coping and social support.
Bigatti SM; Wagner CD; Lydon-Lam JR; Steiner JL; Miller KD; Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2010 Mar 10
Bigatti SM; Wagner CD; Lydon-Lam JR; Steiner JL; Miller KD; Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2010 Mar 10
Synthesis of carbon-11-labeled casimiroin analogues as new potential PET agents for imaging of quinone reductase 2 and aromatase expression in breast cancer.
Wang M; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH; Steroids 2010 Jun 15
Wang M; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH; Steroids 2010 Jun 15
Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer.
Gökmen-Polar Y; Toroni RA; Hocevar BA; Badve S; Zhao Q; Shen C; Bruckheimer E; Kinch MS; Miller KD; Breast cancer research and treatment 2010 Jul 3
Gökmen-Polar Y; Toroni RA; Hocevar BA; Badve S; Zhao Q; Shen C; Bruckheimer E; Kinch MS; Miller KD; Breast cancer research and treatment 2010 Jul 3
Synthesis of carbon-11-labeled tariquidar derivatives as new PET agents for imaging of breast cancer resistance protein (ABCG2).
Wang M; Zheng DX; Luo MB; Gao M; Miller KD; Hutchins GD; Zheng QH; Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2010 Feb 13
Wang M; Zheng DX; Luo MB; Gao M; Miller KD; Hutchins GD; Zheng QH; Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2010 Feb 13
Synthesis and in vitro biological evaluation of carbon-11-labeled quinoline derivatives as new candidate PET radioligands for cannabinoid CB2 receptor imaging.
Gao M; Wang M; Miller KD; Hutchins GD; Zheng QH; Bioorganic & medicinal chemistry 2010 Feb 10
Gao M; Wang M; Miller KD; Hutchins GD; Zheng QH; Bioorganic & medicinal chemistry 2010 Feb 10
Synthesis of carbon-11-labeled 4-aryl-4H-chromens as new PET agents for imaging of apoptosis in cancer.
Gao M; Wang M; Miller KD; Hutchins GD; Zheng QH; Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2009 Sep 26
Gao M; Wang M; Miller KD; Hutchins GD; Zheng QH; Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2009 Sep 26
Design and synthesis of carbon-11-labeled dual aromatase-steroid sulfatase inhibitors as new potential PET agents for imaging of aromatase and steroid sulfatase expression in breast cancer.
Wang M; Mickens J; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH; Steroids 2009 Jun 25
Wang M; Mickens J; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH; Steroids 2009 Jun 25
A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen.
Mina L; Krop I; Zon RT; Isakoff SJ; Schneider CJ; Yu M; Johnson C; Vaughn LG; Wang Y; Hristova-Kazmierski M; Shonukan OO; Sledge GW; Miller KD; Investigational new drugs 2009 Feb 13
Mina L; Krop I; Zon RT; Isakoff SJ; Schneider CJ; Yu M; Johnson C; Vaughn LG; Wang Y; Hristova-Kazmierski M; Shonukan OO; Sledge GW; Miller KD; Investigational new drugs 2009 Feb 13
Synthesis of carbon-11 labeled celecoxib derivatives as new candidate PET radioligands for imaging of inflammation.
Gao M; Wang M; Miller KD; Hutchins GD; Zheng QH; Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2009 Aug 3
Gao M; Wang M; Miller KD; Hutchins GD; Zheng QH; Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2009 Aug 3
The role of vascular endothelial growth factor genetic variability in cancer.
Schneider BP; Radovich M; Miller KD; Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Aug 25
Schneider BP; Radovich M; Miller KD; Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Aug 25
Redefining the target again: chemotherapeutics as vascular disrupting agents?
Gokmen-Polar Y; Miller KD; Cancer cell 2008 Sep 9
Gokmen-Polar Y; Miller KD; Cancer cell 2008 Sep 9
Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.
Schneider BP; Wang M; Radovich M; Sledge GW; Badve S; Thor A; Flockhart DA; Hancock B; Davidson N; Gralow J; Dickler M; Perez EA; Cobleigh M; Shenkier T; Edgerton S; Miller KD; ECOG 2100; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Oct 1
Schneider BP; Wang M; Radovich M; Sledge GW; Badve S; Thor A; Flockhart DA; Hancock B; Davidson N; Gralow J; Dickler M; Perez EA; Cobleigh M; Shenkier T; Edgerton S; Miller KD; ECOG 2100; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Oct 1
Simple synthesis of carbon-11 labeled styryl dyes as new potential PET RNA-specific, living cell imaging probes.
Wang M; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH; European journal of medicinal chemistry 2008 Mar 7
Wang M; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH; European journal of medicinal chemistry 2008 Mar 7
Synthesis of new carbon-11 labeled naphthalene-sulfonamides for PET imaging of human CCR8.
Wang M; Cooley B; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH; Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2008 Mar 20
Wang M; Cooley B; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH; Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2008 Mar 20
Synthesis and preliminary biological evaluation of new carbon-11 labeled tetrahydroisoquinoline derivatives as SERM radioligands for PET imaging of ER expression in breast cancer.
Gao M; Wang M; Miller KD; Sledge GW; Zheng QH; European journal of medicinal chemistry 2008 Jan 11
Gao M; Wang M; Miller KD; Sledge GW; Zheng QH; European journal of medicinal chemistry 2008 Jan 11
Incorporation of antiangiogenic therapies in the treatment of metastatic breast cancer.
Ademuyiwa FO; Miller KD; Clinical breast cancer 2008 Dec
Ademuyiwa FO; Miller KD; Clinical breast cancer 2008 Dec
Development of new targeted therapies for breast cancer.
Doyle DM; Miller KD; Cancer treatment and research 2008
Doyle DM; Miller KD; Cancer treatment and research 2008
Development of new targeted therapies for breast cancer.
Doyle DM; Miller KD; Breast cancer (Tokyo, Japan) 2008
Doyle DM; Miller KD; Breast cancer (Tokyo, Japan) 2008
Antiangiogenic agents in breast cancer.
Salter JT; Miller KD; Cancer investigation 2007 Oct
Salter JT; Miller KD; Cancer investigation 2007 Oct
Synthesis of new carbon-11 labeled cyclofenil derivatives for PET imaging of breast cancer estrogen receptors.
Gao M; Wang M; Mock BH; Miller KD; Sledge GW; Hutchins GD; Zheng QH; Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2007 Nov 19
Gao M; Wang M; Mock BH; Miller KD; Sledge GW; Hutchins GD; Zheng QH; Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2007 Nov 19
Synthesis of carbon-11 labeled biaryl 1,2,3,4-tetrahydroisoquinoline derivatives and conformationally flexible analogues as new potential PET glioma tumor imaging agents.
Wang M; Gao M; Miller KD; Sledge GW; Zheng QH; Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2007 May 31
Wang M; Gao M; Miller KD; Sledge GW; Zheng QH; Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2007 May 31
Comparison of computational algorithms for the classification of liver cancer using SELDI mass spectrometry: a case study.
Shen C; Breen TE; Dobrolecki LE; Schmidt CM; Sledge GW; Miller KD; Hickey RJ; Cancer informatics 2007 Dec 11
Shen C; Breen TE; Dobrolecki LE; Schmidt CM; Sledge GW; Miller KD; Hickey RJ; Cancer informatics 2007 Dec 11
Synthesis of carbon-11 labeled fluorinated 2-arylbenzothiazoles as novel potential PET cancer imaging agents.
Wang M; Gao M; Mock BH; Miller KD; Sledge GW; Hutchins GD; Zheng QH; Bioorganic & medicinal chemistry 2006 Sep 8
Wang M; Gao M; Mock BH; Miller KD; Sledge GW; Hutchins GD; Zheng QH; Bioorganic & medicinal chemistry 2006 Sep 8
Synthesis of radiolabeled stilbene derivatives as new potential PET probes for aryl hydrocarbon receptor in cancers.
Gao M; Wang M; Miller KD; Sledge GW; Hutchins GD; Zheng QH; Bioorganic & medicinal chemistry letters 2006 Sep 6
Gao M; Wang M; Miller KD; Sledge GW; Hutchins GD; Zheng QH; Bioorganic & medicinal chemistry letters 2006 Sep 6
Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer.
James J; Murry DJ; Treston AM; Storniolo AM; Sledge GW; Sidor C; Miller KD; Investigational new drugs 2006 Sep 13
James J; Murry DJ; Treston AM; Storniolo AM; Sledge GW; Sidor C; Miller KD; Investigational new drugs 2006 Sep 13
Synthesis of carbon-11 labeled sulfonanilide analogues as new potential PET agents for imaging of aromatase in breast cancer.
Wang M; Lacy G; Gao M; Miller KD; Sledge GW; Zheng QH; Bioorganic & medicinal chemistry letters 2006 Oct 26
Wang M; Lacy G; Gao M; Miller KD; Sledge GW; Zheng QH; Bioorganic & medicinal chemistry letters 2006 Oct 26
Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue.
Mina L; Soule SE; Badve S; Baehner FL; Baker J; Cronin M; Watson D; Liu ML; Sledge GW Jr; Shak S; Miller KD; Breast cancer research and treatment 2006 Oct 13
Mina L; Soule SE; Badve S; Baehner FL; Baker J; Cronin M; Watson D; Liu ML; Sledge GW Jr; Shak S; Miller KD; Breast cancer research and treatment 2006 Oct 13
Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model.
Shanmugam R; Jayaprakasan V; Gokmen-Polar Y; Kelich S; Miller KD; Yip-Schneider M; Cheng L; Bhat-Nakshatri P; Sledge GW Jr; Nakshatri H; Zheng QH; Miller MA; DeGrado T; Hutchins GD; Sweeney CJ; The Prostate 2006 Oct 1
Shanmugam R; Jayaprakasan V; Gokmen-Polar Y; Kelich S; Miller KD; Yip-Schneider M; Cheng L; Bhat-Nakshatri P; Sledge GW Jr; Nakshatri H; Zheng QH; Miller MA; DeGrado T; Hutchins GD; Sweeney CJ; The Prostate 2006 Oct 1
Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer.
Hochreiter AE; Xiao H; Goldblatt EM; Gryaznov SM; Miller KD; Badve S; Sledge GW; Herbert BS; Clinical cancer research : an official journal of the American Association for Cancer Research 2006 May 15
Hochreiter AE; Xiao H; Goldblatt EM; Gryaznov SM; Miller KD; Badve S; Sledge GW; Herbert BS; Clinical cancer research : an official journal of the American Association for Cancer Research 2006 May 15
Synthesis of [11C]Iressa as a new potential PET cancer imaging agent for epidermal growth factor receptor tyrosine kinase.
Wang JQ; Gao M; Miller KD; Sledge GW; Zheng QH; Bioorganic & medicinal chemistry letters 2006 May 11
Wang JQ; Gao M; Miller KD; Sledge GW; Zheng QH; Bioorganic & medicinal chemistry letters 2006 May 11
A physiologic imaging pilot study of breast cancer treated with AZD2171.
Miller KD; Miller M; Mehrotra S; Agarwal B; Mock BH; Zheng QH; Badve S; Hutchins GD; Sledge GW Jr; Clinical cancer research : an official journal of the American Association for Cancer Research 2006 Jan 1
Miller KD; Miller M; Mehrotra S; Agarwal B; Mock BH; Zheng QH; Badve S; Hutchins GD; Sledge GW Jr; Clinical cancer research : an official journal of the American Association for Cancer Research 2006 Jan 1
Radiosynthesis of carbon-11-labeled camptothecin derivatives as potential positron emission tomography tracers for imaging of topoisomerase I in cancers.
Gao M; Miller KD; Sledge GW; Zheng QH; Bioorganic & medicinal chemistry letters 2005 Sep 1
Gao M; Miller KD; Sledge GW; Zheng QH; Bioorganic & medicinal chemistry letters 2005 Sep 1
Synthesis of [18F]SU11248, a new potential PET tracer for imaging cancer tyrosine kinase.
Wang JQ; Miller KD; Sledge GW; Zheng QH; Bioorganic & medicinal chemistry letters 2005 Oct 1
Wang JQ; Miller KD; Sledge GW; Zheng QH; Bioorganic & medicinal chemistry letters 2005 Oct 1
A multicenter phase II trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with previously treated metastatic breast cancer.
Miller KD; Trigo JM; Wheeler C; Barge A; Rowbottom J; Sledge G; Baselga J; Clinical cancer research : an official journal of the American Association for Cancer Research 2005 May 1
Miller KD; Trigo JM; Wheeler C; Barge A; Rowbottom J; Sledge G; Baselga J; Clinical cancer research : an official journal of the American Association for Cancer Research 2005 May 1
Angiogenesis of breast cancer.
Schneider BP; Miller KD; 2005 Mar 10
Schneider BP; Miller KD; 2005 Mar 10
Breast Cancer
Looking for patient care?
To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.